The Scientist

» pharmaceuticals and developmental biology

Most Recent

image: Fertility Treatment Fallout

Fertility Treatment Fallout

By | January 1, 2015

Mouse offspring conceived by in vitro fertilization are metabolically different from naturally conceived mice.

8 Comments

image: NIH Study Canceled

NIH Study Canceled

By | December 15, 2014

The National Institutes of Health shutters its initiative to track the health of 100,000 children through adulthood.

3 Comments

image: Merck Buys Cubist for $8.4B

Merck Buys Cubist for $8.4B

By | December 11, 2014

Hours after the pharmaceutical giant announced the acquisition, a federal judge invalidated key patents behind the antibiotic maker’s most lucrative product.

0 Comments

image: Pharma and Biotech Firms Hacked

Pharma and Biotech Firms Hacked

By | December 2, 2014

Cyberspies have broken into the e-mails of a number of publicly traded companies, most of which are in health care and pharmaceuticals.

0 Comments

image: Study: Drug Development Costs $2.6B

Study: Drug Development Costs $2.6B

By | November 24, 2014

A new estimate finds the pricetag for taking a drug through the approval process has steadily risen over the past few decades.

0 Comments

image: Push For Data Disclosure

Push For Data Disclosure

By | November 21, 2014

Two federal health agencies released proposed rules that would tighten the requirements for reporting clinical trial results.

0 Comments

image: Mother’s Microbes Protect Baby’s Brain

Mother’s Microbes Protect Baby’s Brain

By | November 19, 2014

Bacteria in the gut of a pregnant mouse strengthen the blood-brain barrier of her developing fetus.

0 Comments

image: Stems Cells Ushered into Embryonic Development

Stems Cells Ushered into Embryonic Development

By | November 7, 2014

The right mix of mouse embryonic stem cells in a dish will start forming early embryonic patterns, according to two studies.

0 Comments

image: Taking Shots at Ebola

Taking Shots at Ebola

By | November 5, 2014

With an infusion of public and private resources and accelerated regulatory processes, a handful of companies are racing to develop a vaccine to curb the Ebola epidemic.

4 Comments

image: Report: Sales for Antibiotics on Farms Rose

Report: Sales for Antibiotics on Farms Rose

By | October 6, 2014

Amid concerns that the use of antibiotics may contribute to drug resistance, sales for use in livestock rose in recent years.

0 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  4. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

RayBiotech